India's Tatva Chintan up on starting commercial production at new facility

Tatva Chintan Pharma Chem

06/04/2023 09:21

** Shares of Tatva Chintan Pharma Chem Ltd  TATV.NS  rise as
much as 3.3% to 1,734.70 rupees, hitting their highest since
March 24
    ** Stock posts biggest intraday pct gain since March 31
    ** Specialty chemicals maker commences commercial production
from new facility at Dahej manufacturing plant in Gujarat 
    ** Moving average convergence divergence line above the
signal line, suggesting bullish momentum    
    ** However, stock has been trading below its 50-, 100-, and
200-day moving averages since Nov. 23, 2022
    ** More than 12,270 shares change hands by 1:40 p.m. IST,
1.3x 30-day avg of 9,373 shares
    ** Four of 5 analysts covering the stock have a "buy" or
higher rating while one rates it at "hold"; median PT is 2526
rupees - Refinitiv data
    ** Stock down 21.9% so far this year, up to last close

 (Reporting by Dimpal Gulwani in Bengaluru)
 ((Dimpal.Gulwani@thomsonreuters.com;))